Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07599696 · ClinicalTrials.gov registry record · NA
Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
A NA study, sponsored by Michigan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07599696 is a NA study that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 100 participants.
The verdict
NCT07599696, a NA study, is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The proposed research aims to investigate the use of speech amplification devices as a potential treatment option for people with Parkinson's disease and related disorders who exhibit hypophonia, a voice disorder that affects over half of those with Parkinson's disease. By characterizing the acoustic and perceptual effects of speech amplification and identifying ways to optimize outcomes through talker- and device-specific enhancements, this project seeks to develop personalized, evidence-based treatment options for hypophonia. The current proposal will move this effort forward by systematically eliciting and modifying speech amplification device output that leverage both behavioral and technological approaches.
Interventions
- BEHAVIORAL Behavioral speech strategies + speech amplification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07599696
The ClinicalTrials.gov registry entry for NCT07599696 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Behavioral speech strategies + speech amplification is the first listed.
NCT07599696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07599696 about?
NCT07599696 is a clinical study titled "Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements". The proposed research aims to investigate the use of speech amplification devices as a potential treatment option for people with Parkinson's disease and related disorders who exhibit hypophonia, a voice disorder that affects over half of those with Parkinson's disease. By characterizing the acousti...
What is the current status of trial NCT07599696?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-03-01. Estimated completion is 2028-05-31.
What interventions are being tested in trial NCT07599696?
The interventions under investigation include: Behavioral speech strategies + speech amplification (BEHAVIORAL).
Who is sponsoring clinical trial NCT07599696?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.